Omvoh 300 mg
Omvoh 300 mg is a medicine authorised by Swissmedic under authorisation number 68950. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 November 2023 and the authorisation is limited until 29 November 2028. ATC code L04AC24 places the medicine in the group Immunosuppressants.
| Authorisation number | 68950 |
|---|---|
| Name | Omvoh 300 mg |
| Full name | Omvoh 300 mg, solution à diluer pour perfusion |
| Authorisation holder | Eli Lilly (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AC24 |
| First authorisation | 30 November 2023 |
| Authorisation validity | 29 November 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Omvoh 300 mg, solution à diluer pour perfusion | B | 30 November 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L04AC24 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Omvoh 300 mg authorised in Switzerland?
Yes. Omvoh 300 mg is authorised by Swissmedic under authorisation number 68950, data as of 01 September 2026. The authorisation is limited until 29 November 2028.
Which dispensing category does Omvoh 300 mg have?
Omvoh 300 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Omvoh 300 mg?
The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.